NanoViricides
NNVC
#10112
Rank
NZ$40.24 M
Marketcap
NZ$2.24
Share price
-1.52%
Change (1 day)
-9.39%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: NZ$40.24 Million

As of December 2025 NanoViricides has a market cap of NZ$40.24 Million. This makes NanoViricides the world's 10112th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$40.24 M5.46%
2024NZ$38.15 M101.42%
2023NZ$18.94 M-6.66%
2022NZ$20.29 M-67.66%
2021NZ$62.76 M47.96%
2020NZ$42.42 M194.07%
2019NZ$14.42 M-30.39%
2018NZ$20.72 M-73.6%
2017NZ$78.48 M-12.7%
2016NZ$89.9 M-9.82%
2015NZ$99.69 M-49.23%
2014NZ$0.19 B-32.82%
2013NZ$0.29 B221.37%
2012NZ$90.95 M-22.08%
2011NZ$0.11 B-55.86%
2010NZ$0.26 B71.31%
2009NZ$0.15 B-9.87%
2008NZ$0.17 B182.32%
2007NZ$60.66 M

End of Day market cap according to different sources

On Dec 11th, 2025 the market cap of NanoViricides was reported to be:

NZ$39.93 Million
by Nasdaq info icon info icon
NZ$40.24 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioCryst Pharmaceuticals
BCRX
NZ$2.74 B 6,721.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$1.86 B 4,546.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$262.96 B 653,341.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$179.28 B 445,403.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$425.39 B 1,056,937.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$169.65 B 421,479.82%๐Ÿ‡ฌ๐Ÿ‡ง UK